Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |